Detalhe da pesquisa
1.
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.
Clin Infect Dis
; 73(10): 1849-1856, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709142